Abstract:Objective To investigate the expressions of TGF-β/Smad signaling pathways and the effects of budesonide on it in asthmatic mice.Methods Kunming mice were randomly divided into four groups,asthmatic model group(group A),therapeutic control group(group B),budesonide treated group(group C),control group(group D).In group A,mice were sensitized and challenged with ovalbumin(OVA) to establish asthmatic model.The sensitive and challenge methods were the same as the asthmatic model,but there was a intervention of aerosolized NS or BUD before an hour of challenge in group B and C respectively.Eosinophils infiltration,mucus secretion and collagen hyperplsia of bronchial tract were observed by HE,PAS and VG stains.The expressions of TGF-β,TGF-β typeⅠand typeⅡreceptor,Smad 2/3,Smad 4 and Smad 7 were measured by immunochemistry and computerized image analysis system.Results The more eosinophils infiltration,the more mucus hyper-secretion and collagen hyperplsia in bronchial tract of asthmatic mice were observed IOD in group A,B,C and D for TGF-β expression were 108.38 ± 15.47,123.17 ± 26.07,117.75 ± 19.75 and 7.88 ± 2.07 respectively,the expressions of group A,B and C were higher than that of group D;TGF-β type Ⅰ receptor were 231.09 ± 37.80,276.87 ± 50.65,124.40 ± 26.75 and 14.99 ± 4.48 respectively,which exhibit the same trend as TGF-β expressions,but there were significant differences between group A and group C.TGF-β type Ⅱ receptor were 200.55 ± 26.49,150.32 ± 31.05,193.72 ± 34.17 and 243.08 ± 54.32 respectively.There were no differences in 4 groups;Smad 2/3 were 206.63 ± 36.19,202.24 ± 28.79,138.87 ± 14.11 and 24.64 ± 6.36 respectively.The expressions of group A,B and C were higher than that of group D.Smad 4 were 129.50 ± 21.51,140.48 ± 19.31,118.70 ± 22.96 and 22.77 ± 4.86.The results were the same as Smad 2/3 expressions.Smad 7 were 19.21 ± 4.65,17.04 ± 6.48,123.95 ± 15.26 and 157.22 ± 21.35 respectively.The expressions of group A and B were obviously lower than that of group C and D,and there were no differences between group C and group D.Conclusions Inhaled budesonide can not inhabit the expressions of TGF-β,TGF-β type Ⅱ receptor,Smad 2/3 and Smad 4 in bronchial tract of asthmatic mice.But it inhibits TGF-β/Smad signaling pathways and then inhibits TGF-β-induced airway remodeling through down regulation of TGF-β typeⅠreceptor expression and up regulation of Smad 7 expression in asthmatic mice.

The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse

Bruton's tyrosine kinase inhibition suppresses neutrophilic inflammation and restores histone deacetylase 2 expression in myeloid and structural cells in a mixed granulocytic mouse model of asthma

Bruton's Tyrosine Kinase Ablation Inhibits B Cell Responses and Antibody Production for the Prevention of Chronic Rejection in Cardiac Transplantation.

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

[Effects of Icariin on Bcl-2 and Bax Protein Expressions and Eosinophils Apoptosis in Bronchial Asthmatic Mice].

IL2-inducible T-cell kinase inhibitor ibrutinib reduces symptoms and Th2 differentiation in mouse allergic-rhinitis model

Bruton's tyrosine kinase inhibition for the treatment of allergic disorders

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Bruton Tyrosine Kinase Inhibition Decreases Inflammation and Differentially Impacts Phagocytosis and Cellular Metabolism in Mouse- and Human-derived Myeloid Cells

Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy

The Effect of Serine Protease Inhibitors on Airway Inflammation in a Chronic Allergen-Induced Asthma Mouse Model

The Chronic and Short-Term Effects of Gefinitib on Airway Remodeling and Inflammation in a Mouse Model of Asthma.

Effect of Bacillus Calmette-Guerin Treatment on Airway Inflammation and T Regulatory Cells in Mice with Asthma

Effect of Budesonide on expression of Janus protein tyrosin kinase 1 and interleukin-4 in mice with asthma

Inhibition of effector B cells by ibrutinib in systemic sclerosis

Mycophenolate Mofetil, an Inhibitor of Inosine Monophosphate Dehydrogenase, and Tofacitinib, a Janus Kinase Inhibitor, Attenuate Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma

Echinacoside alleviates airway remodeling and inflammation in an ovalbumin-induced neonatal mouse model of asthma by modulating the SIRT1-NF-κB pathway

Effects of Bacillus Calmette-Guerin on airway inflammation, T helper cell differentiation and serum OVA-specific IgE levels in a mouse model of asthma

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

The effects of budesonide on the expressions of TGF-β/Smad signaling pathways in asthmatic mice

Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice